Can Metformin Counteract Antipsychotic-Induced Hyperprolactinemia? New Evidence Emerges Medha Baranwal28 March 2025 8:30 PM ISTTaiwan: A recent meta-analysis of randomized controlled trials has highlighted the potential of metformin in reducing antipsychotic-induced...
Very high doses of CBD, a cannabis component, don't affect driving Dr. Kamal Kant Kohli24 Jun 2022 6:30 AM ISTMillions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving. The University of...
Psilocybin-assisted treatment durable against major depressive disorder, study claims Medical Dialogues Editorial Team12 May 2022 12:00 PM ISTUSA: A new article published in the Journal of Psychopharmacology suggests that in certain individuals, the significant antidepressant...
Psilocybin effective in major depression up to a year for most patients, study shows Hina Zahid3 March 2022 9:00 AM ISTPrevious studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms...
Lithium treatment reduces hospitalization risk due to hyponatremia, finds study Medha Baranwal15 Oct 2020 5:00 PM ISTSweden: Electrolyte disturbances are frequent, with up to 30% of hospitalized patients having hyponatraemia. Lithium therapy may decrease the...
CBD a potential treatment for memory-related disorders, study suggests Medha Baranwal2 Sept 2020 6:00 PM ISTLondon UK: Cannabidiol (CBD), a key compound in cannabis, increases cerebral blood flow (CBF) in regions of the brain linked to memory...
Psilocybin provides long-term relief from cancer-related psychiatric distress Medha Baranwal9 Feb 2020 11:45 AM ISTUSA: Psilocybin-assisted psychotherapy holds promise in providing long-term relief from cancer-related depression, anxiety and feelings of...
